- Global Biotechnology Company | CSL
CSL has delivered biotechnology excellence for over a century Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need
- Careers | CSL
CSL was established in Australia in 1916 Over the ensuing years, CSL provided Australians with rapid access to 20th century medical advances including insulin and penicillin, and vaccines against influenza, polio and other infectious diseases
- Global Biotechnology Company | CSL
Our parent company, CSL, headquartered in Melbourne, Australia, employs more than 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries
- We Are CSL | CSL
CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology
- Our Businesses and Products | CSL
CSL is committed to protecting public health and improving and saving the lives of patients with rare and serious diseases through the development, manufacture and reliable supply of high-quality medicines
- Worldwide Locations | CSL
Biotech leader CSL has manufacturing centers, sales offices, and locations to serve patients and public health around the globe
- Global Newsroom | CSL
CSL Seqirus and Vaccine Industrial Company sign landmark Memorandum of Understanding with Ministry of Health to localize manufacturing of cell-based seasonal and pandemic influenza vaccines
- Financial Results and Information | Global Biotechnology Company | CSL
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor Together they help ensure people everywhere get the treatments they need
|